Results 201 to 210 of about 9,942,051 (298)
Clinical safety evaluation of ambient voice technologies in surgical documentation
O'Kane R +6 more
europepmc +1 more source
Safety evaluation of pretomanid, an anti-tuberculosis drug, for the treatment of pregnant and lactating women. [PDF]
Bruning-Barry R +9 more
europepmc +1 more source
Objective Reproductive‐age women with systemic autoimmune and rheumatic diseases (SARDs) have unique information needs related to their SARDs and reproductive health. We sought to understand their use of and receptivity to current and hypothetical generative artificial intelligence (AI) tools for health information‐seeking. Methods We conducted a cross‐
Mariam Arif +5 more
wiley +1 more source
Safety evaluation of an extension of use of the food enzyme phospholipase A1 from a genetically modified <i>Aspergillus oryzae</i> strain NZYM-LJ. [PDF]
EFSA Panel on Food Enzymes (FEZ) +16 more
europepmc +1 more source
Real‐World Safety of Concomitant Colchicine and Statin Therapy
Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan +5 more
wiley +1 more source
Real‑world safety evaluation of tranexamic acid: Signal detection from FAERS and VigiAccess databases. [PDF]
Feng J, Guo C, Zhao S.
europepmc +1 more source
Objective Existing patient‐reported outcome (PRO) measures for systemic sclerosis (SSc) have important limitations, including inadequate coverage of early disease and limited inclusion of diffuse cutaneous (dcSSc) and limited cutaneous (lcSSc) subtypes.
George J. Greene +5 more
wiley +1 more source
Safety evaluation of the food enzyme cellulase from the genetically modified <i>Trichoderma reesei</i> strain NZYM-FS. [PDF]
EFSA Panel on Food Enzymes (FEZ) +20 more
europepmc +1 more source
Generative artificial intelligence (AI) is increasingly being used in rheumatology practice, to assist with tasks such as documentation, record summarization, and clinical decision support. Rheumatologists need a practical approach to determining what evidence and oversight each application requires.
Koushan Kouranloo +2 more
wiley +1 more source

